This inventor holds 6 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignees: Oneday-Biotech and Pharma Ltd., Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., Genesistec Ltd.. Active years: 2014-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2014-2017
Title: The Innovative Contributions of Josef Mograbi
Introduction
Josef Mograbi is a notable inventor based in Tel Aviv, Israel. He has made significant contributions to the field of biotechnology, particularly in the development of compounds with various health benefits. With a total of 6 patents, Mograbi's work focuses on antioxidant, anti-inflammatory, and anti-radiation compounds, among others.
Latest Patents
Mograbi's latest patents include groundbreaking research on potent compounds that exhibit combined antioxidant, anti-inflammatory, anti-radiation, and metal chelating properties. These patents describe short peptides that possess these beneficial properties and outline their methods and uses in clinical and cosmetic applications. Additionally, he has developed compositions and methods aimed at increasing carnitine levels in muscle tissue. These methods utilize thiol-containing short peptides with specific sequences and modifications to treat or prevent diseases affecting muscle tissue.
Career Highlights
Throughout his career, Mograbi has worked with various companies, including Oneday Biotech and Pharma Ltd. and Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His innovative work has positioned him as a key figure in the biotechnology sector.
Collaborations
Mograbi has collaborated with notable colleagues such as Daphne Atlas and Shoshana Keynan, contributing to the advancement of research in his field.
Conclusion
Josef Mograbi's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the development of health-related compounds and applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile